Have a feature idea you'd love to see implemented?
Let us know!
IRON Disc Medicine Inc
Price (delayed)
$65.31
Market cap
$1.94B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.98
Enterprise value
$1.75B
Highlights
The company's debt fell by 9% YoY and by 2.7% QoQ
IRON's EPS has soared by 60% YoY but it is down by 8% from the previous quarter
IRON's equity is up by 30% year-on-year but it is down by 4.3% since the previous quarter
Disc Medicine's net income has shrunk by 61% YoY and by 14% QoQ
Disc Medicine's quick ratio has decreased by 26% YoY and by 22% from the previous quarter
Key stats
What are the main financial stats of IRON
Market
Valuations
Earnings
Shares outstanding
29.76M
Market cap
$1.94B
Enterprise value
$1.75B
Price to earnings (P/E)
N/A
Price to book (P/B)
4.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Net income
-$103.48M
EBIT
-$103.27M
EBITDA
-$102.66M
Free cash flow
-$84.21M
Per share
Balance sheet
Liquidity
EPS
-$3.98
EPS diluted
-$3.98
Free cash flow per share
-$2.81
Book value per share
$15.74
Revenue per share
$0
TBVPS
$16.54
Total assets
$495.15M
Total liabilities
$27.19M
Debt
$1.79M
Equity
$467.96M
Working capital
$467.68M
Debt to equity
0
Current ratio
19.36
Quick ratio
19.13
Net debt/EBITDA
1.86
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-24%
Return on equity
-25.2%
Return on invested capital
-86.6%
Return on capital employed
-22%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRON stock price
How has the Disc Medicine stock price performed over time
Intraday
0.46%
1 week
3.75%
1 month
4.25%
1 year
7.07%
YTD
13.07%
QTD
32.91%
Financial performance
How have Disc Medicine's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$124.88M
Net income
-$103.48M
Gross margin
N/A
Net margin
N/A
The operating income has dropped by 63% year-on-year and by 13% since the previous quarter
Disc Medicine's net income has shrunk by 61% YoY and by 14% QoQ
Growth
What is Disc Medicine's growth rate over time
Valuation
What is Disc Medicine stock price valuation
P/E
N/A
P/B
4.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IRON's EPS has soared by 60% YoY but it is down by 8% from the previous quarter
IRON's equity is up by 30% year-on-year but it is down by 4.3% since the previous quarter
IRON's price to book (P/B) is 18% higher than its last 4 quarters average of 3.5
Efficiency
How efficient is Disc Medicine business performance
Disc Medicine's ROIC has soared by 54% from the previous quarter
Disc Medicine's return on assets has decreased by 13% YoY and by 6% QoQ
The ROE fell by 12% YoY and by 6% QoQ
Dividends
What is IRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRON.
Financial health
How did Disc Medicine financials performed over time
IRON's total liabilities has surged by 55% year-on-year and by 27% since the previous quarter
The total assets is up by 32% year-on-year but it has declined by 3% since the previous quarter
The company's debt is 100% lower than its equity
IRON's debt to equity has shrunk by 100% YoY
IRON's equity is up by 30% year-on-year but it is down by 4.3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.